CSG’s Karpat Tank Debut Can’t Lift the Stock as Short-Seller Storm and NATO Ban Bite

Czechoslovak Group shares tumble 50% from January peak amid short-seller claims, NATO blacklist, and EU funding deadline, while revenue surges to €6.7B and analysts see 100% upside.

A new light tank was unveiled on the floor of the IDEB arms fair in Bratislava this week, yet investors in the Czechoslovak Group (CSG) had other things on their minds. The CFL-120 Karpat, a 34-tonne medium battle vehicle developed in partnership with Turkey’s FNSS, marks the company’s push beyond ammunition into integrated land systems. The market, however, remained fixated on a string of headwinds that have shredded more than half the stock’s value since January.

CSG shares closed at €16.42 on Friday, a stone’s throw from the record low set in early May and 50% below the January peak. The gap to the 50-day moving average of roughly €23 underlines the severity of the sell-off. A report from short-seller Hunterbrook Media published in early May triggered the latest leg of the decline, accusing the Czech holding company of refurbishing old munitions rather than manufacturing new ones. CSG has flatly rejected the claims, pointing to erroneous quotations and previously published facts that it says contradict the narrative.

A second front opened when the NATO Support and Procurement Agency (NSPA) placed CSG’s Spanish subsidiary FMG on a blacklist. The group’s management insists a forensic audit turned up no wrongdoing and that FMG continues to supply individual NATO member states directly. The reputational damage, however, has amplified the selling pressure.

Also looming is a ticking deadline in Brussels. The EU’s SAFE financing programme offers a Slovak framework contract for ammunition at an interest rate of just 1%, provided at least two EU member states participate. That condition expires at the end of May. So far, Romania has denied ministerial-level talks, and Croatia is still weighing its options. If Bratislava fails to secure a partner, funding costs could rise and future CSG orders could be delayed.

Operationally, the company is telling a completely different story. Revenue surged to €6.7 billion last year and the order backlog ballooned to €42 billion. Moody’s recently upgraded CSG’s credit rating to investment grade. Management reaffirmed its 2026 guidance for an operating margin of around 24%.

Analysts remain unanimous in their bullish stance: all nine covering the stock rate it a buy, with a consensus price target near €35 — implying a doubling from current levels. JPMorgan goes further, setting a target of €40. Yet the chasm between expert optimism and market reality has rarely been wider.

The first real test of credibility comes on 20 May, when CSG reports its inaugural quarterly earnings since listing. Investors will be looking for detailed disclosure of IPO-related costs and fresh orders. If the numbers are solid, attention may shift back to the group’s robust operational momentum. For now, the Karpat tank’s debut and the ticking SAFE clock offer two very different narratives of where CSG is heading — and neither has yet convinced the stock to turn around.